MVP 3.80% 41.0¢ medical developments international limited

Ann: Investor Presentation - $30m Capital Raise and FY22 Guidance, page-13

  1. 504 Posts.
    lightbulb Created with Sketch. 69
    Intelligent investor is a joke. The problem with MVP is the cost
    Tramadol or Morphine is a fraction of the price easy to administer etc. Penthrox is great for non health professionals as an emergency aid but for Health Professionals the cost is far to high. Cost benefit analysis doesn't work out well IMO.
    I'm also dirty at Intelligent investor over LLC MME FDV MFG to name a few.
    Last edited by Neverlookback: 11/08/22
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.